OTCMKTS:FSNUY Fresenius SE & Co. 5/7/2025 Earnings Report $12.47 -0.02 (-0.16%) As of 12:50 PM Eastern ProfileEarnings HistoryForecast Fresenius SE & Co. EPS ResultsActual EPS$0.23Consensus EPS $0.22Beat/MissBeat by +$0.01One Year Ago EPSN/AFresenius SE & Co. Revenue ResultsActual Revenue$5.92 billionExpected Revenue$5.41 billionBeat/MissBeat by +$513.12 millionYoY Revenue GrowthN/AFresenius SE & Co. Announcement DetailsQuarterDate5/7/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsFresenius SE & Co.'s next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Fresenius SE & Co. Earnings HeadlinesFresenius Medical in-pact with Coordination of National Institutes in Mexico4 hours ago | msn.comFSNUY Fresenius SE & Co. KGaA - Seeking AlphaJune 28, 2025 | seekingalpha.comTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design. July 3 at 2:00 AM | Crypto 101 Media (Ad)Fresenius: Healthy Portfolio AddJune 7, 2025 | seekingalpha.comFresenius SE price target raised to EUR 52 from EUR 43 at CitiJune 5, 2025 | msn.comThree Days Left Until Fresenius SE & Co. KGaA (ETR:FRE) Trades Ex-DividendMay 22, 2025 | finance.yahoo.comSee More Fresenius SE & Co. Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fresenius SE & Co.? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fresenius SE & Co. and other key companies, straight to your email. Email Address About Fresenius SE & Co.Fresenius SE & Co. (OTCMKTS:FSNUY) KGaA is a global health care group headquartered in Bad Homburg, Germany. Founded in 1912 by pharmacist Eduard Fresenius, the company has grown through strategic acquisitions and innovation to become one of the world’s leading providers of medical products and services. Over more than a century, Fresenius has expanded its footprint across Europe, the Americas, Asia and Africa, serving patients and healthcare professionals in more than 100 countries. The company operates through four core business segments. Fresenius Medical Care specializes in dialysis products and services for patients with chronic kidney failure. Fresenius Kabi develops and manufactures clinical nutrition products, infusion therapies and medical devices for hospital and outpatient care. Fresenius Helios is one of Europe’s largest private hospital operators, overseeing more than 130 acute care hospitals and numerous outpatient centers. VAMED provides project management, technical services and solutions for healthcare facilities, supporting clients from planning and construction through operations and maintenance. Fresenius places a strong emphasis on research and development, investing in innovations ranging from biopharmaceutical manufacturing to digital health solutions. Its leadership team is headed by Chief Executive Officer Dr. Stephan Sturm and Chief Financial Officer Dr. Marcus Both, under the oversight of a Supervisory Board chaired by Georg Funke. With a commitment to improving patient outcomes and increasing access to quality care, the company continues to pursue strategic partnerships and sustainable growth initiatives in key markets worldwide.Written by Jeffrey Neal JohnsonView Fresenius SE & Co. ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs Upcoming Earnings Bank of America (7/14/2025)America Movil (7/15/2025)Bank of New York Mellon (7/15/2025)BlackRock (7/15/2025)Citigroup (7/15/2025)JPMorgan Chase & Co. (7/15/2025)Progressive (7/15/2025)Charles Schwab (7/15/2025)UnitedHealth Group (7/15/2025)Wells Fargo & Company (7/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
